Cyclosporin A (CsA) is a potent immunosuppressive agent that has signi
ficantly improved graft survival in organ- and bone-marrow-transplant
recipients. However, in the context of graft transplantation, CsA has
been suggested to potentiate vascular disease by stimulating smooth-mu
scle cell (SMC) proliferation. As previous studies on the effect of Cs
A on smooth-muscle proliferation have afforded conflicting results, we
conducted an in vitro study of the effect of two concentrations of Cs
A-10(-6) M (corresponding to the maximal concentration in patients) an
d 10(-7) M (corresponding to trough concentrations)-on cultured rat SM
C proliferation, as assessed by [H-3]thymidine incorporation into DNA
and measuring cell number by a colorimetric method based on the quanti
tative staining of cell nuclei. In the presence of 0.5% fetal calf ser
um (FCS), 10(-6) M CsA induced an increase in [H-3]thymidine incorpora
tion into DNA (from 614.44 +/- 67.76 to 1,472.6 +/- 177.63 cpm/well; p
< 0.05) with no increase in the number of cells. A cytotoxic effect f
or this dose was ruled out owing to the absence of significant levels
of lactate dehydrogenase (LDH) activity in the supernatant. CsA, 10(-7
) M, induced an increase in both [H-3]thymidine incorporation into DNA
(from 614.44 +/- 67.76 to 1,220.91 +/- 145.59 cpm/well) and cell numb
er (82.39 +/- 6.16 to 165.79 +/- 10.48 cells x 10(3); p < 0.05). In th
e presence of 10% FCS, the highest CsA concentration increased [H-3]th
ymidine incorporation to 2,115.91 +/- 224.06 cpm/well, with no signifi
cant changes in cell number. However, the lowest CsA concentration inc
reased both [H-3]thymidine incorporation (to 3,752.58 +/- 525.06 cpm/w
ell) and cell number (to 181.27 +/- 14.2 cells x 10(3)). These finding
s suggest that the proliferative effect of CsA on SMCs is variable and
that it depends on the concentration of the drug, in support of the d
iscordant results reported previously.